Valeant, Actavis and Mylan circle Pfizer generics unit ahead of split

16-01-2014 Irish TimesComments (0)

GenericsValeant Pharmaceuticals

Drugmakers Valeant Pharmaceuticals International, Actavis and Mylan have all expressed interest in buying Pfizer's branded generics business, but no active discussions are going on at this time, according to three people close to the matter. The ...

Read more on Irish Times

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top